Morningstar Investment Services’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-55,840
Closed -$761K 252
2021
Q4
$761K Buy
55,840
+2,529
+5% +$34.5K 0.01% 183
2021
Q3
$873K Buy
53,311
+1,049
+2% +$17.2K 0.01% 174
2021
Q2
$880K Buy
52,262
+2,029
+4% +$34.2K 0.01% 174
2021
Q1
$922K Sell
50,233
-2,923
-5% -$53.7K 0.01% 168
2020
Q4
$967K Sell
53,156
-5,247
-9% -$95.5K 0.01% 168
2020
Q3
$1.07M Sell
58,403
-3,679
-6% -$67.2K 0.02% 163
2020
Q2
$1.12M Sell
62,082
-4,493
-7% -$81.3K 0.02% 159
2020
Q1
$1.04M Sell
66,575
-32,715
-33% -$512K 0.02% 161
2019
Q4
$1.96M Sell
99,290
-5,208
-5% -$103K 0.03% 134
2019
Q3
$1.8M Sell
104,498
-6,410
-6% -$110K 0.03% 128
2019
Q2
$1.96M Sell
110,908
-8,185
-7% -$145K 0.03% 147
2019
Q1
$2.43M Buy
+119,093
New +$2.43M 0.04% 143